| An introduction to the epidemiology and burden of urinary tract infections |
18 |
| Renal trauma: the current best practice |
17 |
| Holmium laser versus thulium laser enucleation of the prostate: a matched-pair analysis from two centers |
10 |
| Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia |
7 |
| An update on the best approaches to prevent complications in penile prosthesis recipients |
7 |
| Anatomical, surgical and technical factors influencing continence after radical prostatectomy |
7 |
| Risk factors and predisposing conditions for urinary tract infection |
6 |
| Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction |
6 |
| Paratesticular sarcomas: a case series and literature review |
6 |
| Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction |
6 |
| Appropriate use of antibiotics: an unmet need |
5 |
| Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapies |
5 |
| A review of avelumab in locally advanced and metastatic bladder cancer |
5 |
| Circulating tumor cells in genitourinary tumors |
5 |
| Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base |
4 |
| Analysis of psychosocial stress factors in patients with renal cancer |
4 |
| Real-time indocyanine green angiography with the SPY fluorescence imaging platform decreases benign ureteroenteric strictures in urinary diversions performed during radical cystectomy |
4 |
| Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of real-life' studies |
4 |
| The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol |
4 |
| Contemporary best practice urolithiasis in pregnancy |
4 |
| Intralesional collagenase Clostridium histolyticum in the management of Peyronie's disease: current best practice |
4 |
| Current best practice management of interstitial cystitis/bladder pain syndrome |
4 |
| Detection rates of recurrent prostate cancer: (68)Gallium (Ga)-labelled prostate-specific membrane antigen versus choline PET/CT scans. A systematic review |
4 |
| Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects |
4 |
| The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy |
4 |
| Radical cystectomy in frail octogenarians in thoracic continuous spinal anesthesia and analgesia: a pilot study |
4 |
| Prevention of recurrent urinary tract infections: bridging the gap between clinical practice and guidelines in Latin America |
3 |
| Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model |
3 |
| Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: first-in-human trial |
3 |
| Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study |
3 |
| Cabozantinib in the treatment of advanced renal cell carcinoma in adults following prior vascular endothelial growth factor targeted therapy: clinical trial evidence and experience |
3 |
| The continuing role of chemotherapy in the management of advanced urothelial cancer |
3 |
| Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study |
3 |
| Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection |
3 |
| Once-daily 5 mg tadalafil oral treatment for patients with chronic prostatitis/chronic pelvic pain syndrome |
3 |
| Appraisal of the role of radical prostatectomy for rhabdomyosarcoma in children: oncological and urological outcome |
3 |
| Aquablation: a novel and minimally invasive surgery for benign prostate enlargement |
3 |
| Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer |
3 |
| Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjects |
3 |
| Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care |
2 |
| Opportunities for use of radiation therapy in penile cancer based on patterns of care in the United States from 2007 to 2013 |
2 |
| A review of optimal prostate biopsy: indications and techniques |
2 |
| Robot-assisted laparoscopic pyeloplasty versus laparoscopic pyeloplasty for pelvi-ureteric junction obstruction in the paediatric population: a systematic review and meta-analysis |
2 |
| Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences |
2 |
| Advances in the management of upper tract urothelial carcinoma: improved endoscopic management through better diagnostics |
2 |
| Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation |
2 |
| Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials |
2 |
| Urogenital tuberculosis, the cause of ineffective antibacterial therapy for urinary tract infections |
2 |
| Outcomes of open artificial urinary sphincter in women with stress urinary incontinence: long-term follow up |
2 |
| Optimization of renal function preservation during robotic partial nephrectomy |
2 |
